Development of a Novel Simplified PBPK Absorption Model to Explain the Higher Relative Bioavailability of the OROS® Formulation of Oxybutynin
- Authors
- A Avdeef
- A Bruyere
- A Dokoumetzidis
- A Dokoumetzidis
- A Dokoumetzidis
- A Okazaki
- A Olivares-Morales
- A Olivares-Morales
- A Rostami-Hodjegan
- A Rostami-Hodjegan
- A Shibukawa
- Amin Rostami-Hodjegan
- Andrés Olivares-Morales
- AS Darwich
- Avijit Ghosh
- B Agoram
- C Tannergren
- D Cong
- D Hallifax
- DM Mudie
- E Chen
- E Hénin
- E Sjogren
- E Sjogren
- E Sjögren
- EM Howgate
- G Langdon
- G Sathyan
- G Sathyan
- GL Amidon
- H Lennernas
- H Lennernas
- H Mizushima
- HF Helander
- I Poggesi
- IA Nestorov
- International Commission on Radiological Protection
- J Douchamps
- J Valentin
- J Wang
- J Yang
- J Yang
- JA Foster
- JA Jacquez
- JC Kolars
- K Johnson
- K Rowland Yeo
- K Sugano
- K Sugano
- K Sugano
- K Thelen
- KC Johnson
- KR Godfrey
- Leon Aarons
- LR Williams
- LX Yu
- LX Yu
- LX Yu
- LX Yu
- M Anguelova
- M Bouchoucha
- M Bouchoucha
- M Gertz
- M Jamei
- M Jamei
- M Pitsiu
- M Rowland
- M Taketani
- M Yaich
- M Zur
- MF Paine
- MF Paine
- MN Martinez
- MV Varma
- N Parrott
- N Tsamandouras
- NW Read
- P Poulin
- P Zhao
- P Zhao
- PJ Matheson
- R Bauer
- R Conley
- RJ Hintz
- S Willmann
- SK Gupta
- SK Gupta
- SS Davis
- T Rodgers
- T Rodgers
- Y Cao
- Y Sato
- Publication date
- Publisher
- 'American Association of Pharmaceutical Scientists (AAPS)'
- Doi